For achieving Deloitte’s high standards for innovation, showing great potential, and exceling in our field.
We proudly announce that Enantis launched a new website today. With launch of our new website, we are introducing our re-defined corporate identity and visuals. Our new logo consists of a simplified protein molecule. It reinforces our goal to use our expert know-how and computing tools to make the complicated process of protein engineering simpler and deliver you the results faster. We are your protein pro team.
We are happy to announce that Gabin de La Bourdonnaye joined our team as a foreign Ph.D. student under the Marie Curie Initial Training Network. Gabin will be working on modification of proteins for medical and biotechnological applications by directed evolution.
A new substance we’re working on at Enantis could help change how doctors heal wounds. Its researchers adjusted a specific growth protein that can help skin repair itself much faster than normal.
We succeeded in the European Business Champions League – H2020 SME Instrument phase 2. Among the thousands of applicants from all across Europe, Enantis was the only Czech company to receive both phase 1 and phase 2 grant. The company will receive more than €1 million to finance its preclinical trial study for its project, and will also benefit from business coaching.